// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Physiological Significance of Lysophosphatidylinositol/G Protein-coupled Receptor 55 System in the Regulation of Platelet Function

A. Gadd - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

PI3KC2β Deficiency Stabilizes Adherens Junctions and Preserves Vascular Integrity in Stroke Models

T. Anquetil - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Plasma Concentration of Activated Factor VII-antithrombin, But Not Tissue Factor Pathway Inhibitor and Factor VII Levels, Predicts Mortality in Subjects with Liver and Colon Cancer Undergoing Curative Surgical Intervention

D. De Santis - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Platelet Activation and Aggregation Induced by NS1 Dengue Protein

M.E. Viveros-Sandoval - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Epinephrine

Platelet Ageing Is Associated with Cytoskeletal Degradation and a Reduction in Cytoskeletal Dynamics

H.E. Allan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Platelet Procoagulant Membrane Dynamics in Cardiac Surgery with Cardiopulmonary Bypass: Outcomes of a Pilot Study

A.J. Gregory - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Protamine Sulfate

Platelet-targeted Magnetic Nanoparticles Enhance the Efficacy of Thrombolysis through Induction of Magnetic Hyperthermia

D. Cabrera - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Neuroleptic malignant syndrome

PAC-1

Platelets Induce Rapid Subset and Phenotypic Switching in Monocytes in Whole Blood

N. Roth - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pre – Analytical Variables in Haemostasis: Results of the UK National External Quality Assessment Scheme for Blood Coagulation Haemolysis Supplementary Exercise

L. Brown - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Fibrinogen (IV)

Pregnancy Complications and Outcomes in Women with Moderate and Severe von Willebrand Disease (VWD)

O. Turan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE

C. Jerjes-Sanchez - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Profiling of COX-dependent Eicosanoids Produced by Blood Cells and the Vasculature

M. Crescente - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prophylaxis with Turoctocog Alfa Pegol (N8-GP) Maintains Improvements in Health-Related Quality of Life (HRQoL) and Treatment Satisfaction (TS) over ≥4.5 Years in Patients with Haemophilia A (HA)

P. Giangrande - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

NN7008

Prospective Study of Haemostatic Activation Markers and Correlation with Bleeding and Thrombotic Complications in Patients Receiving Veno-Venous Extra-Corporeal Membrane Oxygenation (VV-ECMO) – HAE Study

D. Jayakody Arachchillage - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Heparin

Quality of Life Outcomes after Iliac Vein Stenting for Chronic Deep Venous Obstruction: A Tertiary Centre Experience Using the VEINES-QoL/Sym

R. Morris - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Real World Efficacy of Emicizumab in Haemophilia A with Inhibitors: A Report from the UK National Haemophilia Database

C. Wall - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

Real World Experience of Major Surgery and Delivery in Von Willebrand Disease

B. Craven - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Tranexamic acid

Reduction of Venous Thromboembolic Events in Hospitalized Patients with Coronavirus Disease 2019 after Intensification of Thromboprophylaxis

P. Filippidis - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Reference Ranges of HJHS Scores in Healthy Adult Males without Hemophilia

J. St-Louis - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Rheumatoid arthritis

N/A

Relevance of Thrombin in the Activation of the Fluid Contact Phase in Patients with Hereditary Angioedema Carrying the F12 p.Thr309Lys Variant

M.E. de la Morena-Barrio - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hereditary angioedema

Dextran sulfate

Copyright © 2026. QuantiNova All rights reserved